1. MARKET RESEARCH ON
PHARMACEUTICALS IN INDIA
Reference code: IRRMRRMAR11-03
Published On: 15Mar2011
www.internationalresearchreport.com
India Malaysia Singapore
#42, II Floor, 3, Jalan BP 3/17, 7500ª Beach Road
Venkatarathinam Nagar, Bandar Bukit Puchonga, #08-313, the Plaza
Adyar, Chennai. 47100 Puchong, Singapore 199591
Tamil Nadu, India Selangor Darul Ehsan, Malaysia
Market Research on Indian Pharmaceutical @IRR
This profile is a licensed product and is not to be photocopied

2. PRESS RELEASE
Pharmaceutical market worldwide is witnessing increased opportunities in the area
of Bio Pharmaceuticals, Pharmacogenomics and the organic market. India is one of the fastest-
growing pharmaceutical markets in the world, and its market size has nearly doubled since
2005, and also expected to reach US$ 20 billion by 2015.
India is the third-largest market in the world in terms of volume and fourteenth in terms of
value. The government began to encourage the growth of drug manufacturing companies in
India in the 1960's, and the Patent Act in 1970 allowed the industry to become what it is today
Pharma industry is mounting at a swift rate in India, while a hold back in the growth has
been encountered in US. Our report “Pharmaceutical in India” forecast to 2020, Pharma
(clinical) industry of India is estimated to increase at a CAGR during 2008 – 2011, nearly dual the
global average.
The forecast caters a understanding scrutinize Indian pharmaceutical market, covering its
exports of pharmaceutical products, technical capability, cost efficiency, government support
and clinical research. It also supplemented with figures.
Statistical information is from 2000 – 2020 and analysis is conducted in US$ million.
Market Research on Indian Pharmaceutical @IRR 2
This profile is a licensed product and is not to be photocopied

3. REPORT HIGHLIGHTS AND FEATURES
Report Highlights:
 Market Volume and Forecast
 Indian Market distribution of Key Competitors
 Population and Epidemiological Statistics for the Indian Market
 Pharmaceutical Market by Product Category
 Profiles of Key Companies in India
Report Features:
 Market Analysis of Indian Pharmaceuticals Industry in 2005-2015
 Growth Analysis of Pharmaceuticals Industry worldwide
 Estimation of the involvement of Multinational Pharmaceuticals companies
in the domestic pharmaceuticals market.
 Growth Drivers-Technical capability, cost efficiency, government support.
 Key trends –growing global demand for generics, launch of patented
molecules, rural market opportunities.
Market Research on Indian Pharmaceutical @IRR 3
This profile is a licensed product and is not to be photocopied

4. CONTENTS
India Advantage
 India Advantages –vision 2011
Market Analysis
 Market volume of the Indian pharmaceutical industry
 Market segments-CRAMS, Formulations, API
 Exports of pharmaceutical products
 Growth Drivers on Technical capability
 Growth Drivers on Cost Efficiency
 Growth Drivers on Government support
 Key trends for growing global demand for generics
 Key trends for launch of patented molecules
 Key trends for rural market opportunities
 Key players-Leading Indian Players by Sales (US$ Billions)
Industry Infrastructure
 Various Special Economic Zones in India
Investments
 Cumulative FDI inflow November2000 to August 2010
 M&A Scenario from January 2010-October 2010
 Investments by acquirer
Strategy and Regulatory outline
 Strategy and Regulatory outline for Pharma industry
 Central & State Government Policies
 Measurement for Budget & Policy
Scope
 Indian Pharmaceuticals R&D Expenditure
 Count on ANDA –US FDA approval
 Outsourcing market in India
 Market size forecast of Indian Clinical Research Market (US$Billions)
 Future Opportunities in biosimilars (US$ Billions)
Key Contacts
Market Research on Indian Pharmaceutical @IRR 4
This profile is a licensed product and is not to be photocopied

5. LIST OF TABLES AND FIGURES
List of Tables:
Table 1: Growth drivers — government support
Table 2: launch of patented molecules
Table 3: Leading Indian Key players by sales (US$ million)
Table 4: Leading foreign Key players by sales (US$ million)
Table 5: M&A scenario _ Cumulative FDI inflow (November 2000 – October 2010)
Table 6: Investments Key Deals
Table 7: Scopes – Research and development
List of Figures:
Figure 1: Advantage India
Figure 2: Market size of the Indian pharmaceutical industry
Figure 3: Pharmaceuticals_Market segments
Figure 4: Exports of pharmaceutical products
Figure 5: US FDA-approved plants
Figure 6: Percentage overall indexed manufacturing cost (US FDA-approved plants)
Figure 7: Global generics market
Figure 8: Location of pharmaceutical SEZs in India
Figure 9: Strategy and Regulatory outline (Central Government & State Government)
Figure 10: Percentage increase in outsourcing activities
Figure 11: Market size forecast for Indian clinical research market (US$ million)
Figure 12: Future opportunity in biosimilars (US$ billion)
Market Research on Indian Pharmaceutical @IRR 5
This profile is a licensed product and is not to be photocopied

6. Report Summary:
Report Title: MARKET RESEARCH ON PHARMACEUTICALS IN INDIA
Reference code: IRRMRRMAR11-03
Published On: 15Mar2011
Published by: IRR [International Research Report]
Pages: 35 pages
Price: 50USD
Contact Us
Email us: info@internationalresearchreport.com / cking.sg@gmail.com
Website: www.internationalresearchreport.com
Contact No: +91- 9840995095/ +91-(44)-45504412
Market Research on Indian Pharmaceutical @IRR 6
This profile is a licensed product and is not to be photocopied